Mohamed Emam Sobeih, Head of the Oncology Department at Al-Mahwar Hospital, shared a post on LinkedIn:
“Honored to have participated as a speaker at the recent conference in Tashkent, Uzbekistan!
I presented on the critical topic of overcoming resistance mechanisms in EGFR-mutant NSCLC.
It was an excellent opportunity to share insights on emerging strategies and discuss the challenges we face in extending the benefit of targeted therapy for our patients.
Thank you to the organizers for a successful event and to my fellow attendees for the engaging discussion. Let’s continue to collaborate on this vital research!”
More posts featuring Mohamed Emam Sobeih.